FMP
Tenax Therapeutics, Inc.
TENX
NASDAQ
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
5.61 USD
0.14 (2.5%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Christopher T. Giordano
sector
Healthcare
industry
Biotechnology
website
https://www.tenaxthera.comexchange
NASDAQ
Description
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax The...
CIK
0000034956
ISIN
US88032L6056
CUSIP
88032L209
Address
ONE Copley Parkway
Phone
919 855 2100
Country
US
Employee
5
IPO Date
Apr 4, 1994
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
TENX Financial Summary
CIK
0000034956
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
88032L209
ISIN
US88032L6056
Country
US
Price
5.61
Beta
2.15
Volume Avg.
64.25k
Market Cap
19.12M
Shares
-
52-Week
2.77-27.36
DCF
0.89
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.43
P/B
-
Website
https://www.tenaxthera.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest TENX News
It looks like there's no news available.
